Literature DB >> 29381465

Pitfalls of prioritizing cost-effectiveness in the assessment of medical innovation.

Christopher J D Wallis1, Allan S Detsky2.   

Abstract

Year:  2017        PMID： 29381465      PMCID： PMC5937407          DOI： 10.5489/cuaj.5068

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  7 in total

1.  Ontario's formulary committee: how recommendations are made.

Authors:  Anne M PausJenssen; Peter A Singer; Allan S Detsky
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

2.  Health technology assessment. Evaluation of biomedical innovative technologies.

Authors:  Giuseppe Turchetti; Enza Spadoni; Eliezer Elie Geisler
Journal:  IEEE Eng Med Biol Mag       Date:  2010 May-Jun

3.  Relevance of cost-effectiveness analysis to clinicians and policy makers.

Authors:  Allan S Detsky; Andreas Laupacis
Journal:  JAMA       Date:  2007-07-11       Impact factor: 56.272

4.  Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada.

Authors:  Fiona M Clement; Anthony Harris; Jing Jing Li; Karen Yong; Karen M Lee; Braden J Manns
Journal:  JAMA       Date:  2009-10-07       Impact factor: 56.272

5.  Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study.

Authors:  John W Yaxley; Geoffrey D Coughlin; Suzanne K Chambers; Stefano Occhipinti; Hema Samaratunga; Leah Zajdlewicz; Nigel Dunglison; Rob Carter; Scott Williams; Diane J Payton; Joanna Perry-Keene; Martin F Lavin; Robert A Gardiner
Journal:  Lancet       Date:  2016-07-26       Impact factor: 79.321

Review 6.  Robotic Surgical System for Radical Prostatectomy: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2017-07-07

7.  Surgeon volume and operative mortality in the United States.

Authors:  John D Birkmeyer; Therese A Stukel; Andrea E Siewers; Philip P Goodney; David E Wennberg; F Lee Lucas
Journal:  N Engl J Med       Date:  2003-11-27       Impact factor: 91.245
  7 in total
  2 in total

1.  Pitfalls of prioritizing cost-effectiveness in the assessment of medical innovation: A comment on Wallis and Detsky guest editorial.

Authors:  Mike Paulden; Christopher Mccabe
Journal:  Can Urol Assoc J       Date:  2017-12-22       Impact factor: 1.862

2.  Inaccuracies and omissions in editorial about robotic-assisted prostatectomy.

Authors:  Irfan A Dhalla; Nancy Sikich
Journal:  Can Urol Assoc J       Date:  2017-12-01       Impact factor: 1.862
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.